COVID-19 and HSCT (Hematopoietic stem cell transplant)
Author:
Publisher
Elsevier BV
Subject
Clinical Biochemistry,Oncology
Reference75 articles.
1. Guidelines for COVID-19 management in hematopoietic cell transplantation and cellular therapy recipients;Waghmare;Biol Blood Marrow Transplant,2020
2. Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee
3. The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy;Ljungman;Bone Marrow Transplant,2020
4. Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey;Passweg;Bone Marrow Transplant,2022
5. Changes in stem cell transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian bone marrow transplant group (GITMO) nationwide analysis (TransCOVID-19 survey);Russo;Bone Marrow Transplant,2021
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Outcomes of hematopoietic stem cell transplantation in patients with SARS-CoV-2 infection during the Omicron era;International Journal of Infectious Diseases;2024-10
2. Features of the T-cell immune response in patients with hematological diseases after SARS-CoV-2 infection and vaccination;Russian journal of hematology and transfusiology;2024-08-18
3. Strategic infection prevention after genetically modified hematopoietic stem cell therapies: recommendations from the International Society for Cell & Gene Therapy Stem Cell Engineering Committee;Cytotherapy;2024-07
4. Impact of COVID‐19 monoclonal antibodies on outcomes of COVID‐19 infection in hematopoietic stem cell transplant and chimeric antigen receptor therapy recipients;Transplant Infectious Disease;2024-06-27
5. Nirmatrelvir/ritonavir treatment of patients with COVID-19 taking tacrolimus: case series describing the results of drug–drug interactions;Journal of International Medical Research;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3